These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 3115927

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
    Arteaga CL, Hanauske AR, Clark GM, Osborne CK, Hazarika P, Pardue RL, Tio F, Von Hoff DD.
    Cancer Res; 1988 Sep 01; 48(17):5023-8. PubMed ID: 3165707
    [Abstract] [Full Text] [Related]

  • 3. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA, Ehya H, Lang WR.
    Acta Cytol; 1987 Sep 01; 31(4):448-52. PubMed ID: 3604540
    [Abstract] [Full Text] [Related]

  • 4. [Expression of transforming growth factor beta-3 (TGF-beta-3) on reactive and malignant cells in ascites and pleural effusion].
    Munker R, Darsow M, Stötzer O, Kremer JP, Mezger J.
    Med Klin (Munich); 1994 May 15; 89(5):248-51. PubMed ID: 8052178
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP, Baxevanis CN, Papadopoulos NG, Zarkadis IK, Papacostas P, Michailakis E, Tsiatas ML, Papamichail M.
    Anticancer Res; 1996 May 15; 16(6B):3855-60. PubMed ID: 9042270
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
    Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF.
    Cancer Res; 1993 Jun 15; 53(12):2912-8. PubMed ID: 8504432
    [Abstract] [Full Text] [Related]

  • 11. The metabolic behaviour of the cellular populations in the pleural or peritoneal effusions from patients with malignant diseases.
    Mihăilescu E, Micu D, Cheţa N, Chiriloiu C, Georgescu M, Vilău C.
    Med Interne; 1986 Jun 15; 24(3):227-33. PubMed ID: 2430328
    [Abstract] [Full Text] [Related]

  • 12. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ, Vooijs GP.
    Acta Cytol; 1988 Jun 15; 32(2):183-7. PubMed ID: 3348059
    [Abstract] [Full Text] [Related]

  • 13. High level of beta-type transforming growth factor activity in human urine obtained from cancer patients.
    Nishimura R, Okumura H, Noda K, Yasumitsu H, Umeda M.
    Jpn J Cancer Res; 1986 Jun 15; 77(6):560-7. PubMed ID: 3089989
    [Abstract] [Full Text] [Related]

  • 14. Cytomorphological and immunocytochemical study of non-Hodgkin's lymphoma in pleural effusion and ascitic fluid.
    Das DK, Al-Juwaiser A, George SS, Francis IM, Sathar SS, Sheikh ZA, Shaheen A, Pathan SK, Haji BE, George J, Kapila K.
    Cytopathology; 2007 Jun 15; 18(3):157-67. PubMed ID: 17488258
    [Abstract] [Full Text] [Related]

  • 15. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES, Bohn WH, Cockley KD, Warren TC, Sherwin SA.
    Cancer Res; 1984 Aug 15; 44(8):3613-9. PubMed ID: 6331653
    [Abstract] [Full Text] [Related]

  • 16. Determination of transforming growth factor activity in effusions from cancer patients.
    Hanauske AR, Arteaga CL, Clark GM, Buchok J, Marshall M, Hazarika P, Pardue RL, Von Hoff DD.
    Cancer; 1988 May 01; 61(9):1832-7. PubMed ID: 3162700
    [Abstract] [Full Text] [Related]

  • 17. An immunoperoxidase study of S-100 protein in neoplastic cells in serous effusions. Use as a marker for melanoma.
    Pinto MM.
    Acta Cytol; 1986 May 01; 30(3):240-4. PubMed ID: 3521174
    [Abstract] [Full Text] [Related]

  • 18. Tumor microenvironment: what can effusions teach us?
    Kassis J, Klominek J, Kohn EC.
    Diagn Cytopathol; 2005 Nov 01; 33(5):316-9. PubMed ID: 16240401
    [Abstract] [Full Text] [Related]

  • 19. [Ascites and pleural effusion. Study and follow-up of 79 patients].
    Molina M, Ortega G, Vidal L, Montoya JJ, Pérez A, García B.
    Rev Esp Enferm Apar Dig; 1989 Oct 01; 76(4):375-8. PubMed ID: 2595069
    [Abstract] [Full Text] [Related]

  • 20. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F, Lühr I, Kunze T, Mundhenke C, Maass N, Erhart T, Denker M, Beckmann D, Tiemann M, Schulte C, Dohrmann P, Cavaillé F, Godeau F, Gespach C.
    Thromb Haemost; 2007 Jun 01; 97(6):1023-30. PubMed ID: 17549306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.